CERE - Cerevel Corp Bozor kapitallashuvining daromadga nisbati
Cerevel Therapeutics (CERE) tadqiqotlar uchun xomashyo yetkazib beruvchilarning optimallashtirilgan tarmog'idan foydalangan holda, faol birikmalarni aniqlashni tezlashtirish uchun avtomatlashtirilgan skrining platformalarini joriy qilmoqda. Daromadni baholash ko'rsatkichi narxlar dinamikasini aks ettiradi, qiymati esa joriy bozor baholovini tasdiqlaydi. Kompaniya ulkan markaziy nerv tizimi (CNS) dori bozorini nishonga olgan holda, Parkinson kasalligi va shizofreniya uchun terapiya vositalarini ishlab chiqishga e'tibor qaratmoqda.
Cerevel Therapeutics (CERE) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Cerevel Therapeutics|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Cerevel Therapeutics|CERE - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Cerevel Therapeutics|CERE - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Cerevel Therapeutics|Shoshilinch likvidlik cerevel.com
- foyda va bozor koeffitsiyentlari statistikasi:
CERE - Sof daromad|Prognoz qilingan kelajakdagi foyda Cerevel Therapeutics|CERE - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Cerevel|CERE - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Cerevel Corp|CERE - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Cerevel Therapeutics|CERE - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi cerevel.com|CERE - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Cerevel Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:CERE Cerevel Therapeutics Inc
Cerevel Therapeutics (CERE) laboratoriya robototexnikasi orqali nevrologik dori vositalarini kashf qilish jarayonini optimallashtirmoqda, bu esa xarajatlarni kamaytiradi va aktivlarining bozor qiymatiga ta'sir ko'rsatadi. Ushbu narx-savdo koeffitsiyenti joriy bozor kapitalizatsiyasini haqiqiy savdo hajmi bilan bog'laydi, bu esa investorlarga hisobotlar oralig'ida biznes modelining samaradorligini zudlik bilan baholash va kompaniyaning kelgusidagi daromadli bo'lishiga bo'lgan bozor kutuvlari qanchalik haddan tashqari yuqori ekanligini aniqlash imkonini beradi.
Cerevel Therapeutics raqobatchilari
BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Neumora (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|TVGN - Narx/daromad koeffitsiyenti|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati cogrx.com (CGTX)|Narxning daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Narx/daromad koeffitsiyenti Cassava Sciences|P/S multiplikatori ASRT (Assertio Holdings)|COYA - Kapitalizatsiyaning daromadga nisbati|vistagen.com - P/S multiplikatori|OVID: Narxning daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning daromadga nisbati|CervoMed Inc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati PEPG (PepGen Inc)|P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiya va daromad nisbati|Grace Tx - P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiya va daromad nisbati|KLTO: P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - P/S multiplikatori|Narxning daromadga nisbati Reviva Pharmaceuticals, Inc.|Kapitalizatsiyaning daromadga nisbati metaviatx.com (MTVA)|P/S multiplikatori NRXS|HSDT - Sotuvga nisbatan narx|Passage Bio, Inc. - Kapitalizatsiyaning daromadga nisbati|bionomics.com.au (NEUP) - Sotuvga nisbatan narx|Minerva - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ATHA (Athira Pharma Inc)|ADXN: P/S multiplikatori|Kapitalizatsiya va daromad nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - P/S multiplikatori|PTIX (Protagenic Therapeutics) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori KTTA|Narx/daromad koeffitsiyenti Cortigent|P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning daromadga nisbati|Cara Therapeutics Inc. - P/S multiplikatori|Chromocell Therapeutics (CHRO) - Kapitalizatsiyaning daromadga nisbati|ELYM: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - P/S multiplikatori|Marinus - Narxning sotuvga nisbati|P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SAGE (Sage Therapeutics Inc)|Narx/daromad koeffitsiyenti Synaptogenix Inc. (SNPX)|TRVN - Narxning daromadga nisbati|vigilneuro.com (VIGL) - Kapitalizatsiyaning daromadga nisbati|WENA: P/S multiplikatori
